FDA TO LAY OFF ANDRO; DENVER WRITER CHASTISED FOR SNOOPING

          The FDA "said it has no reason to step up scrutiny" of
     androstenedione after all the attention the product has
     received this week, according to Kristin Reed of BLOOMBERG
     NEWS.  FDA spokesperson Ruth Welch: "The FDA is not aware
     that this product used in the marketplace presents a hazard
     to the public health" (BLOOMBERG NEWS, 8/28).  Meanwhile,
     the ATP Tour banned androstenedione and will inform players
     of the move before the U.S. Open on Monday.  The ruling
     "adds to the ban instituted" by the ITF (N.Y. TIMES, 8/28).
          CAUGHT SNOOPING: The BBWAA has "suspended" Denver Post
     columnist Mark Kiszla until the end of the regular season
     after he was "seen picking up" a bottle of Andro-6 from
     Rockies LF Dante Bichette's locker during batting practice
     Wednesday, "a time when the clubhouse generally is closed to
     all media."  Kiszla later addressed the team in a clubhouse
     meeting on Thursday.  The Rockies also revoked Kiszla's
     credentials (Tony Jackson, ROCKY MOUNTAIN NEWS, 8/28).